Bernstein raised the firm’s price target on HCA Healthcare (HCA) to $503 from $486 and keeps a Market Perform rating on the shares. The firm sees a sector turnaround in the government managed care organization sector beginning in 2026, but expects to see bumps in the recovery. Bernstein believes all MCO sectors present attractive entry points, with Medicare Advantage likely to see the nearest term earnings improvements and Medicaid representing the most attractive valuations.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target lowered to $495 from $520 at Truist
- HCA Healthcare price target raised to $520 from $505 at Mizuho
- HCA Healthcare downgraded to Underweight from Equal Weight at Morgan Stanley
- Hospital stocks lower after Republicans propose Medicare funding cut
- HCA Healthcare price target raised to $431 from $412 at Wells Fargo